title: Treatment of psoriatic arthritis with etanercept.
authors.forename: P
authors.initials: P
authors.lastname: Kurschat
authors.forename: A
authors.initials: A
authors.lastname: Rubbert
authors.forename: A
authors.initials: A
authors.lastname: Poswig
authors.forename: K
authors.initials: K
authors.lastname: Scharffetter-Kochanek
authors.forename: T
authors.initials: T
authors.lastname: Krieg
authors.forename: N
authors.initials: N
authors.lastname: Hunzelmann
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000494:pharmacology*; D015535:Arthritis, Psoriatic / Q000188:drug therapy* / Q000473:pathology; D002097:C-Reactive Protein / Q000032:analysis; D006233:Persons with Disabilities; D000068800:Etanercept; D006801:Humans; D007074:Immunoglobulin G / Q000008:administration & dosage / Q000494:pharmacology*; D007249:Inflammation; D007279:Injections, Subcutaneous; D008297:Male; D008875:Middle Aged; D010146:Pain; D018124:Receptors, Tumor Necrosis Factor / Q000008:administration & dosage; D016896:Treatment Outcome; D016138:Walking
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D002097:C-Reactive Protein; D000068800:Etanercept